Inovio Pharmaceuticals Statistics
Total Valuation
INO has a market cap or net worth of $73.35 million. The enterprise value is $16.26 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INO has 36.67 million shares outstanding. The number of shares has increased by 37.06% in one year.
| Current Share Class | 36.67M |
| Shares Outstanding | 36.67M |
| Shares Change (YoY) | +37.06% |
| Shares Change (QoQ) | +28.74% |
| Owned by Insiders (%) | 1.31% |
| Owned by Institutions (%) | 28.63% |
| Float | 33.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 218.96 |
| Forward PS | n/a |
| PB Ratio | 1.43 |
| P/TBV Ratio | 1.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 57.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.22.
| Current Ratio | 2.63 |
| Quick Ratio | 2.55 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -132.44% and return on invested capital (ROIC) is -77.74%.
| Return on Equity (ROE) | -132.44% |
| Return on Assets (ROA) | -61.21% |
| Return on Invested Capital (ROIC) | -77.74% |
| Return on Capital Employed (ROCE) | -176.77% |
| Revenue Per Employee | $2,113 |
| Profits Per Employee | -$719,992 |
| Employee Count | 134 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.00% in the last 52 weeks. The beta is 1.31, so INO's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | -78.00% |
| 50-Day Moving Average | 1.91 |
| 200-Day Moving Average | 3.26 |
| Relative Strength Index (RSI) | 47.44 |
| Average Volume (20 Days) | 678,115 |
Short Selling Information
The latest short interest is 6.57 million, so 17.91% of the outstanding shares have been sold short.
| Short Interest | 6.57M |
| Short Previous Month | 7.01M |
| Short % of Shares Out | 17.91% |
| Short % of Float | 19.86% |
| Short Ratio (days to cover) | 11.65 |
Income Statement
In the last 12 months, INO had revenue of $283,099 and -$96.48 million in losses. Loss per share was -$3.11.
| Revenue | 283,099 |
| Gross Profit | -70.51M |
| Operating Income | -105.96M |
| Pretax Income | -121.64M |
| Net Income | -96.48M |
| EBITDA | -104.27M |
| EBIT | -105.96M |
| Loss Per Share | -$3.11 |
Full Income StatementBalance Sheet
The company has $68.36 million in cash and $11.27 million in debt, giving a net cash position of $57.09 million or $1.56 per share.
| Cash & Cash Equivalents | 68.36M |
| Total Debt | 11.27M |
| Net Cash | 57.09M |
| Net Cash Per Share | $1.56 |
| Equity (Book Value) | 51.25M |
| Book Value Per Share | 1.40 |
| Working Capital | 44.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$102.19 million and capital expenditures -$511,627, giving a free cash flow of -$102.70 million.
| Operating Cash Flow | -102.19M |
| Capital Expenditures | -511,627 |
| Free Cash Flow | -102.70M |
| FCF Per Share | -$2.80 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -37,430.19% |
| Pretax Margin | -34,079.58% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -37.06% |
| Shareholder Yield | -37.06% |
| Earnings Yield | -131.54% |
| FCF Yield | -140.02% |
Dividend DetailsAnalyst Forecast
The average price target for INO is $9.75, which is 387.50% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.75 |
| Price Target Difference | 387.50% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 309.40% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 0.0833333:1.
| Last Split Date | Jan 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0833333:1 |
Scores
INO has an Altman Z-Score of -28.64. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -28.64 |
| Piotroski F-Score | n/a |